Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
Novartis blocked from selling Neupogen copycat until Sept. 2
Yahoo/Reuters
Tue, 07/21/15 - 12:47 pm
Novartis
biosimilars
Neupogen
Zarxio
Sandoz
Amgen
Sanofi cholesterol drug, GSK malaria shot may get EU okay Friday
Yahoo/Reuters
Tue, 07/21/15 - 10:30 am
GSK
Sanofi
Europe
Praluent
malaria
PCSK9 inhibitors
Repatha
Amgen
The Pharma Industry Thinks It Finally Has a Fix for Migraines
Yahoo/Bloomberg
Tue, 07/21/15 - 10:17 am
migraines
Teva Pharmaceutical
Amgen
Eli Lilly
Alder Biopharma
CGRPs
Amgen Wins EU Approval to Be First in New Cholesterol Drug Class
Bloomberg
Tue, 07/21/15 - 10:11 am
Amgen
Europe
PCSK9 inhibitors
Repatha
Amgen reports positive preliminary results on leukemia drug
Yahoo/Reuters
Thu, 07/16/15 - 06:34 pm
Amgen
Blincyto
acute lymphoblastic leukemia
Amgen awaiting FDA decision on cancer drug Kyprolis
BioPharma Dive
Tue, 07/14/15 - 11:44 am
Amgen
FDA
Kyprolis
Multiple Myeloma
Amgen's Single Most Important FDA Decision of 2015 Is Nearly Here
Motley Fool
Thu, 07/9/15 - 07:46 pm
Amgen
FDA
Multiple Myeloma
Kyprolis
Merck cancer drugs and Sanofi, Amgen cardio meds have formularies on high alert
Fierce Pharma
Fri, 06/26/15 - 12:46 pm
Merck
Sanofi
Amgen
formulary
Amgen Dazzles With a Duo of Fresh Data
Investopedia
Wed, 06/24/15 - 08:20 am
Amgen
Blincyto
Vectibix
AMG 334
Amgen's cancer drug meets main goal in a late-stage study
Yahoo/Reuters
Thu, 06/18/15 - 06:13 pm
Amgen
Vectibix
colorectal cancer
Is Amgen About to Enter a Battle Over Billions?
Investopedia
Tue, 06/16/15 - 09:10 am
Amgen
Sanofi
Regeneron
Repatha
Praluent
PCSK9 inhibitors
Survey shows doctors ready for PCSK9s
Medical Marketing and Media
Mon, 06/15/15 - 04:24 pm
physicians
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
What You May Have Missed in Biotech: Cholesterol Drug Scrutiny and a Hedge Fund Alzheimer's Play
Forbes
Sat, 06/13/15 - 10:36 am
biotech
GSK
Axovant Sciences
Alzheimer's disease
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Repatha
Amgen
Why Is Amgen Rising And Regeneron Falling?
Barron's
Fri, 06/12/15 - 10:44 am
Amgen
Regeneron
Sanofi
Repatha
Praluent
FDA
advisory panels
PCSK9 inhibitors
This Trial Could Be Worth Billions to Amgen
Investopedia
Wed, 06/10/15 - 09:48 pm
Amgen
Repatha
PCSK9 inhibitors
FDA panel backs Amgen's cholesterol drug for high-risk patients
Yahoo/Reuters
Wed, 06/10/15 - 06:13 pm
FDA
Amgen
Repatha
advisory panels
PCSK9 inhibitors
How The New Cholesterol Drugs From Amgen And Regeneron Could Still Be Blockbusters
Forbes
Wed, 06/10/15 - 09:08 am
Amgen
Regeneron
PCSK9 inhibitors
Repatha
Praluent
This Key Amgen Drug Is Setting a Precedent
Investopedia
Tue, 06/9/15 - 09:55 am
Amgen
Neupogen
Zarxio
Novartis
biosimilars
PCSK9 adcomm preview: what's at stake
Medical Marketing and Media
Tue, 06/9/15 - 09:32 am
PCSK9 inhibitors
FDA
advisory panels
Sanofi
Regeneron
Amgen
Repatha
Praluent
Amgen's Repatha lowers LDL, no marked safety events-FDA staff
Yahoo/Reuters
Mon, 06/8/15 - 10:06 am
Amgen
Repatha
FDA
LDL cholesterol
Pages
« first
‹ previous
…
50
51
52
53
54
55
56
57
58
…
next ›
last »